30/10/2026
New for 2026: introducing our Industry Partners session at the Promega Biologics Symposium.
This year, for the first time, we're widening the symposium's scope beyond assay science to include perspectives from organisations shaping the commercial, regulatory, and intellectual property landscape around biologics development.
Dr Roona Deb, Principal Chartered (UK) and European Patent Attorney at Marks & Clerk LLP, will present From Discovery to Defensible Asset: Building Patentable Value in Biologics R&D, drawing on over 15 years of advising life sciences clients on securing and maximising the value of their intellectual property.
Nikhil Rautela, Senior Strategic Customer Development Manager at US Pharmacopeia (USP), will present USP Standards and Solutions for Analytical Characterisation of mAbs and Gene Therapy Products, bringing a standards and quality perspective to biologics characterisation.
Join us on Thursday, 5 November 2026 at Bee House, Milton Park, Oxfordshire, to hear from both speakers and explore this new dimension of the symposium.
Register now at: https://ow.ly/SE5h50ZZN35